null

SMILES: OC(=O)CCC\C=C/C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3cc(ccc3c2c1)[N+]([O-])=O

InChI Key: InChIKey=ZMBBKVGMOIMAPX-ODJFZNCDSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50060451   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Prostaglandin D2 receptor (Homo sapiens (Human))	BDBM50060451 ((+) 7-[3-(7-Nitro-dibenzofuran-2-sulfonylamino)-bi...) Show SMILES OC(=O)CCC\C=C/C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3cc(ccc3c2c1)[N+]([O-])=O Show InChI InChI=1S/C26H28N2O7S/c29-25(30)6-4-2-1-3-5-20-16-7-8-17(13-16)26(20)27-36(33,34)19-10-12-23-22(15-19)21-11-9-18(28(31)32)14-24(21)35-23/h1,3,9-12,14-17,20,26-27H,2,4-8,13H2,(H,29,30)/b3-1-/t16-,17+,20+,26+/m0/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	250	n/a	n/a	n/a	n/a	n/a	n/a
Shionogi & Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of cAMP formation evoked by the prostaglandin D2 receptor in human platelets				J Med Chem 40: 3504-7 (1997) Article DOI: 10.1021/jm970343g BindingDB Entry DOI: 10.7270/Q2959GP9
					More data for this Ligand-Target Pair
Prostacyclin receptor (Homo sapiens (Human))	BDBM50060451 ((+) 7-[3-(7-Nitro-dibenzofuran-2-sulfonylamino)-bi...) Show SMILES OC(=O)CCC\C=C/C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3cc(ccc3c2c1)[N+]([O-])=O Show InChI InChI=1S/C26H28N2O7S/c29-25(30)6-4-2-1-3-5-20-16-7-8-17(13-16)26(20)27-36(33,34)19-10-12-23-22(15-19)21-11-9-18(28(31)32)14-24(21)35-23/h1,3,9-12,14-17,20,26-27H,2,4-8,13H2,(H,29,30)/b3-1-/t16-,17+,20+,26+/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Shionogi & Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of cAMP formation by carbacyclin in Prostaglandin I2 receptor (IP) assay				J Med Chem 40: 3504-7 (1997) Article DOI: 10.1021/jm970343g BindingDB Entry DOI: 10.7270/Q2959GP9
					More data for this Ligand-Target Pair
Prostaglandin D2 receptor (Homo sapiens (Human))	BDBM50060451 ((+) 7-[3-(7-Nitro-dibenzofuran-2-sulfonylamino)-bi...) Show SMILES OC(=O)CCC\C=C/C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3cc(ccc3c2c1)[N+]([O-])=O Show InChI InChI=1S/C26H28N2O7S/c29-25(30)6-4-2-1-3-5-20-16-7-8-17(13-16)26(20)27-36(33,34)19-10-12-23-22(15-19)21-11-9-18(28(31)32)14-24(21)35-23/h1,3,9-12,14-17,20,26-27H,2,4-8,13H2,(H,29,30)/b3-1-/t16-,17+,20+,26+/m0/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Shionogi & Co., Ltd. Curated by ChEMBL					Assay Description In vitro inhibition of [3H]- PGD-2 radioligand binding to prostaglandin D2 receptor on human platelet membrane				J Med Chem 46: 2436-45 (2003) Article DOI: 10.1021/jm020517g BindingDB Entry DOI: 10.7270/Q2154GFS
					More data for this Ligand-Target Pair
Prostaglandin D2 receptor (Homo sapiens (Human))	BDBM50060451 ((+) 7-[3-(7-Nitro-dibenzofuran-2-sulfonylamino)-bi...) Show SMILES OC(=O)CCC\C=C/C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3cc(ccc3c2c1)[N+]([O-])=O Show InChI InChI=1S/C26H28N2O7S/c29-25(30)6-4-2-1-3-5-20-16-7-8-17(13-16)26(20)27-36(33,34)19-10-12-23-22(15-19)21-11-9-18(28(31)32)14-24(21)35-23/h1,3,9-12,14-17,20,26-27H,2,4-8,13H2,(H,29,30)/b3-1-/t16-,17+,20+,26+/m0/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	57	n/a	n/a	n/a	n/a	n/a	n/a
Shionogi & Co., Ltd. Curated by ChEMBL					Assay Description In vitro inhibition of cAMP formation evoked by prostaglandin D2 receptor in human platelets				J Med Chem 46: 2436-45 (2003) Article DOI: 10.1021/jm020517g BindingDB Entry DOI: 10.7270/Q2154GFS
					More data for this Ligand-Target Pair
Prostaglandin D2 receptor (Homo sapiens (Human))	BDBM50060451 ((+) 7-[3-(7-Nitro-dibenzofuran-2-sulfonylamino)-bi...) Show SMILES OC(=O)CCC\C=C/C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3cc(ccc3c2c1)[N+]([O-])=O Show InChI InChI=1S/C26H28N2O7S/c29-25(30)6-4-2-1-3-5-20-16-7-8-17(13-16)26(20)27-36(33,34)19-10-12-23-22(15-19)21-11-9-18(28(31)32)14-24(21)35-23/h1,3,9-12,14-17,20,26-27H,2,4-8,13H2,(H,29,30)/b3-1-/t16-,17+,20+,26+/m0/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
Shionogi & Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of [3H]-PGD-2 specific binding to Prostaglandin D2 receptor fromhuman platelet membranes				J Med Chem 40: 3504-7 (1997) Article DOI: 10.1021/jm970343g BindingDB Entry DOI: 10.7270/Q2959GP9
					More data for this Ligand-Target Pair